0256: Value of Contrast Enhanced Ultrasound in Diagnosis of Early Hepatocellular Carcinoma

Min-Hua Chen
DOI: https://doi.org/10.1016/j.ultrasmedbio.2009.06.112
IF: 3.694
2009-01-01
Ultrasound in Medicine & Biology
Abstract:To identify enhancing phases of liver in contrast enhanced ultrasound (CEUS) and enhancing features of hepatocellular carcinoma (HCC). CEUS were performed in 253 HCC of 206 patients with liver cirrhosis. The enhancing start times after injection for hepatic artery, portal vein, and liver parenchyma and peak parenchymal enhancing time were recorded. Enhancing patterns of HCC were also analyzed. The diagnostic value of CEUS for HCC was evaluated. CEUS process is divided into four phases after contrast injection: arterial phase (5.8 - 18.4 seconds) begins when hepatic artery shows enhancement, portal venous phase (8.7 - 23.8 seconds) begins when portal vein shows enhancement, parenchymal phase (17.6 - 38.1 seconds) begins when parenchymal enhancement reaches peak, and delayed phase (180 - 360 seconds). In 253 HCC, 94.1% (238 lesions) showed arterial enhancement, and 5.9% (15 lesions) portal enhancement. There were 7.5% (19 lesions) HCC washed out in portal venous phase, 77.1% (195 lesions) in parenchymal phase, and 11.1% (28 lesions) in delayed phase. Eleven HCC (4.3%) showed no contrast wash out. In arterial phase, 60.1% of the HCC showed gross homogeneous enhancement, 33.2% showed heterogeneous enhancement or necrosis, and 2.4% peripheral nodular enhancement. There were 4.3% HCC showed delayed enhancement. There were 53.4% HCC showed basket-like feeding vessels or tortuous vessels inside the tumor in arterial phase. “Early-in-early-out” and “early-in-late-out” patterns were seen in 91.7% HCC, and 2.4% were “early-in-no-out”. Atypical patterns of “late-in-early-out” and “late-in-late/no-out” were seen in 6% HCC. CEUS diagnostic criteria of HCC is proposed based on enhancing timings, enhancing and wash out patterns of the lesions.
What problem does this paper attempt to address?